Rep. Louise Slaughter, of New York, was chairwoman of the rules committee when Democrats were in the majority in the House from 2007 to 2010. The panel controls the debate and amendment process on the House floor, and she used its power to advance the Affordable Care Act, which passed the House by just five votes in 2009.
from Kaiser Health News http://ift.tt/2tZ85gR
March 19, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
‘A Lot Of Promise’: DeepMind Algorithm Detects Serious Kidney Condition In Minutes, But Miss Rate Is HighAcute kidney injury is caused by serious health conditions, including sepsis, and affects one in five people admitted to hospital. Quick diagnosis can save lives. While the machine learning system can reduce the time between … Read More
Georgia’s Hopes For Generous Federal Funding To Expand Medicaid Dim Following Utah RejectionA main component of Georgia's plan had been to request that the federal government fund 90% of the cost to expand Medicaid in the state. But the big federal funding bump looks unlikely: the Trump administration this past week… Read More
New Hampshire Study Shines Light On Strong Link Between Childhood Traumas, Substance Misuse Later In LifeThe research from a drug court program shows that 75% of the participants suffered adverse childhood experiences. A psychologist with Greater Nashua Mental Health noted while this finding is "kind of an obvious thing,'' she h… Read More
With Health Law Vote, Senate Dems Hope To Put Republicans On Record Against Preexisting Conditions CoverageSenate Democrats unveiled plans to force a vote on a Trump administration guidance that could make it easier for states to get waivers from the health law's requirements. The vote is mostly political, as the legislation is un… Read More
Price-Fixing Investigation: Patients Say They Couldn’t Afford Crucial Psychiatric Drug After Generic Companies Hiked CostPatients say a month's supply of a drug called clomipramine suddenly jumped from $16 to $348. Taro Pharmaceuticals Industries Ltd., Mylan Pharmaceuticals Inc. and Novartis AG's generics arm, Sandoz, are facing a court challen… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment